Header Logo

Connection

Naoko Takebe to Oligonucleotides, Antisense

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Oligonucleotides, Antisense.
Naoko Takebe
Connection Strength
0.016
Oligonucleotides, Antisense
  1. Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. J Clin Oncol. 2005 Jun 20; 23(18):4089-99.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.